Analyst Upgrades – Agios Pharmaceuticals (NASDAQ:AGIO) Stock Gets Upgraded By Leerink Swann from Market Perform to Outperform

ME Staff
-
0

Analyst Ratings For Agios Pharmaceuticals (NASDAQ:AGIO)

Today, Agios Pharmaceuticals (NASDAQ:AGIO) stock received an upgrade by Leerink Swann from Market Perform to Outperform.

There are 3 hold ratings, 8 buy ratings on the stock.

The current consensus rating on Agios Pharmaceuticals (NASDAQ:AGIO) is Buy (Score: 2.73) with a consensus target price of $62.88 per share, a potential 7.20% upside.

Some recent analyst ratings include

  • 8/2/2017-Leerink Swann Upgrade from a “Market Perform ” rating to a ” Outperform” rating.
  • 8/1/2017-Janney Montgomery Scott Reiterated Rating of Hold.
  • 6/11/2017-Cann Reiterated Rating of Buy.
  • 4/18/2017-Credit Suisse Group Reiterated Rating of Outperform.
  • 2/16/2017-Cowen and Company Reiterated Rating of Buy.

Recent Insider Trading Activity For Agios Pharmaceuticals (NASDAQ:AGIO)
Agios Pharmaceuticals (NASDAQ:AGIO) has insider ownership of 10.55% and institutional ownership of 84.24%.

  • On 7/20/2017 Lewis Clayton Jr. Cantley, Director, sold 9,000 with an average share price of $56.36 per share and the total transaction amounting to $507,240.00. View SEC Filing
  • On 7/19/2017 Lewis Clayton Jr. Cantley, Director, sold 3,500 with an average share price of $56.14 per share and the total transaction amounting to $196,490.00. View SEC Filing
  • On 7/7/2017 Scott Biller, Insider, sold 2,146 with an average share price of $55.00 per share and the total transaction amounting to $118,030.00. View SEC Filing
  • On 7/3/2017 David P Schenkein, CEO, sold 3,000 with an average share price of $51.18 per share and the total transaction amounting to $153,540.00. View SEC Filing
  • On 6/21/2017 Scott Biller, Insider, sold 4,292 with an average share price of $55.00 per share and the total transaction amounting to $236,060.00. View SEC Filing
  • On 6/14/2017 Lewis Clayton Jr. Cantley, Director, sold 2,000 with an average share price of $50.87 per share and the total transaction amounting to $101,740.00. View SEC Filing
  • On 6/7/2017 David P Schenkein, CEO, sold 3,000 with an average share price of $50.02 per share and the total transaction amounting to $150,060.00. View SEC Filing

Recent Trading Activity for Agios Pharmaceuticals (NASDAQ:AGIO)
Shares of Agios Pharmaceuticals closed the previous trading session at 58.65 0.00 0.00% with 2,149,385 shares trading hands.